These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 27606455)
1. Which patent and where? Why international patent transparency by companies is needed for medicines. Beall RF; Attaran A Nat Biotechnol; 2016 Sep; 34(9):923-6. PubMed ID: 27606455 [No Abstract] [Full Text] [Related]
2. Research on the pharmaceutical intellectual property protection and supervision of pharmacy administration. Xu Z; Chen W Pak J Pharm Sci; 2017 May; 30(3(Special)):1081-1087. PubMed ID: 28671085 [TBL] [Abstract][Full Text] [Related]
3. [Specificities of patent protection in the pharmaceutical industry: modalities and traits of intellectual property]. Jannuzzi AH; Vasconcellos AG; de Souza CG Cad Saude Publica; 2008 Jun; 24(6):1205-18. PubMed ID: 18545747 [TBL] [Abstract][Full Text] [Related]
4. Patent law protection of inventions in medicine and pharmaceutical industry. Miladinović Z; Varga S; Radojković M Vojnosanit Pregl; 2013 Jun; 70(6):600-5. PubMed ID: 23885528 [No Abstract] [Full Text] [Related]
5. Patent quality. Sklan A Pharm Pat Anal; 2014 Jan; 3(1):17-24. PubMed ID: 24354975 [TBL] [Abstract][Full Text] [Related]
6. International patent protection for HIV-related therapies: patent attorney's perspective. Pavento LC; Greene JL; McDonald JK Emory Int Law Rev; 2003; 17(2):919-31. PubMed ID: 15199935 [No Abstract] [Full Text] [Related]
8. International intellectual property strategies for therapeutic antibodies. Storz U MAbs; 2011; 3(6):596-606. PubMed ID: 22123063 [TBL] [Abstract][Full Text] [Related]
9. Enforcing pharmaceutical and biotech patent rights in China. Zhang YP; Deng MM Nat Biotechnol; 2008 Nov; 26(11):1235-40. PubMed ID: 18997760 [No Abstract] [Full Text] [Related]
10. Patents and human rights: a heterodox analysis. Gold ER J Law Med Ethics; 2013; 41(1):185-98. PubMed ID: 23581665 [TBL] [Abstract][Full Text] [Related]
11. Effectively managing an IP portfolio? Not an easy task. Pontremoli G Pharm Pat Anal; 2020 Jan; 9(1):7-8. PubMed ID: 32008443 [No Abstract] [Full Text] [Related]
12. U.S. patent law. Case probes what's fair game in the search for new drugs. Kintisch E Science; 2005 Apr; 308(5719):174. PubMed ID: 15821048 [No Abstract] [Full Text] [Related]
13. USA-Morocco deal may extend drug patents to 30 years. Ahmad K Lancet; 2003 Dec; 362(9399):1904. PubMed ID: 14672079 [No Abstract] [Full Text] [Related]
14. IP issues facing researchers by Gino D'Oca. Almarsson O; Angiolini M; Baell J; Giardina G; Ingham A; Hughes A; Pevarello P; Sindelar R Pharm Pat Anal; 2012 May; 1(2):129-35. PubMed ID: 24236778 [TBL] [Abstract][Full Text] [Related]
15. Bioterrorism and patent rights: "compulsory licensure" and the case of Cipro. Resnik DB; DeVille KA Am J Bioeth; 2002; 2(3):29-39. PubMed ID: 12230852 [No Abstract] [Full Text] [Related]
16. Patent portfolio management: literature review and a proposed model. Conegundes De Jesus CK; Salerno MS Expert Opin Ther Pat; 2018 Jun; 28(6):505-516. PubMed ID: 29718747 [TBL] [Abstract][Full Text] [Related]
17. Patent protection for medical technologies: why some and not others? Melzer D Lancet; 1998 Feb; 351(9101):518-9. PubMed ID: 9482467 [No Abstract] [Full Text] [Related]
18. Trans-Pacific Partnership Provisions in Intellectual Property, Transparency, and Investment Chapters Threaten Access to Medicines in the US and Elsewhere. Baker BK PLoS Med; 2016 Mar; 13(3):e1001970. PubMed ID: 26954325 [TBL] [Abstract][Full Text] [Related]
19. Obtaining, challenging and enforcing pharmaceutical patents under the America Invents Act. Genieser LH; McCann CE Pharm Pat Anal; 2012 Sep; 1(4):415-26. PubMed ID: 24236880 [TBL] [Abstract][Full Text] [Related]